LOGIN  |  REGISTER
C4 Therapeutics

Recent Insider Transactions - Cadrenal Therapeutics (NASDAQ: CVKD)

Follow NASDAQ:CVKD Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ CVKD Cadrenal Therapeutics
MURPHY JOHN RAYMOND / director
01/23/2025
Buy
$19.79
20,000
$396K
20,000
NASDAQ CVKD Cadrenal Therapeutics
WILSON GLYNN / director
01/23/2025
Buy
$19.79
20,000
$396K
20,000
NASDAQ CVKD Cadrenal Therapeutics
Zelenkofske Steven / director
01/23/2025
Buy
$19.79
20,000
$396K
20,000
NASDAQ CVKD Cadrenal Therapeutics
Cole Jeffrey Scott / officer: Chief Operating Officer
01/23/2025
Buy
$19.79
25,000
$495K
25,000
NASDAQ CVKD Cadrenal Therapeutics
Szot Matthew K / officer: Chief Financial Officer
01/23/2025
Buy
$19.79
50,000
$990K
50,000
NASDAQ CVKD Cadrenal Therapeutics
Pham Quang X / director, 10 percent owner, officer: CEO and Chairman
01/23/2025
Buy
$21.77
65,000
$1.415M
65,000
NASDAQ CVKD Cadrenal Therapeutics
Lisicki Robert / director
01/23/2025
Buy
$19.79
20,000
$396K
20,000
NASDAQ CVKD Cadrenal Therapeutics
Cole Jeffrey Scott / officer: Chief Operating Officer
02/01/2025
Sell
$0.94
150,000
$141K
0

  Research Tools
  News & Announcements
  Popular Topics
  Miscellaneous